Browsing by Subject "lääkehoito"

Selective mutism is a children’s psychiatric disorder. Children with selective mutism won’t talk in certain situations, for example in school, despite talking at home with family members. Previously selective mutism was seen as an independent disorder. Research has shown that selective mutism has prominent comorbidity with anxiety disorder, therefore selective mutism is now seen as a specific children’s anxiety disorder or as a symptom of social phobia. Since anxiety plays a notable role in selective mutism, treatments to decrease anxiety have been used to treat selectively mute children. Selective mutism has been shown to be a resilient disorder. Longer duration of symptoms makes the treatment more challenging. Selective mutism is a rare disorder and because of that there is a limited amount of research of selective mutism and its treatment. Most of the research are case studies. Controlled experiments that includes control groups are rare. Clinicians may find it hard to propose a certain treatment for selectively mute patient since there is not unified treatment recommendations. Cognitive-behavioral interventions are primary when treating selective mutism. These interventions include for example self-modeling, stimulus fading and rewarding. Patient’s muteness creates extra challenge, and parents are usually essential help during the assessment and treatment. If therapeutic treatment doesn’t seem to be efficient, medical treatment can be considered. Selective serotonin reuptake inhibitor (SSRI), fluoxetine, is found to be effective when treating adults with social anxiety and some researchers have presented its applicability to treat children’s selective mutism. More research of the treatment of selective mutism is needed to be able to give the best evidence-based information for the clinicians who are dealing with selectively mute patients. Because selective mutism is such a rare disorder, it would be desirable to collect research data internationally and work together with researchers from different countries. Reliable estimations of treatment possibilities could be made if big enough data could be collected.